News | Ultrasound Imaging | March 21, 2018

New Optoacoustic Sensor Visualizes Calcium in Living Animals

Technique offers improved visualization without genetic modification of cells or radiation exposure

March 21, 2018 — Key processes in the body are controlled by the concentration of calcium in and around cells. A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have developed the first sensor molecule that is able to visualize calcium in living animals with the help of a radiation-free imaging technique known as optoacoustics. The method does not require the cells to be genetically modified and involves no radiation exposure.

Calcium is an important messenger in the body. In nerve cells, for example, calcium ions determine whether signals are relayed to other nerve cells. And whether a muscle contracts or relaxes depends on the concentration of calcium in the muscle cells. This is also true of the most vital muscle in our body – the heart.

“Because calcium plays such an important role in essential organs such as the heart and brain, it would be interesting to be able to observe how calcium concentrations change deep within living tissues and in this way to improve our understanding of disease processes. Our sensor molecule is a small first step in this direction,” said Gil Gregor Westmeyer, head of the study and professor of molecular imaging at TUM and research group leader at Helmholtz Zentrum München. In the study, which was published in in the Journal of the American Chemical Society, Prof. Thorsten Bach of the TUM’s Department of Chemistry was also involved. The researchers have already tested their molecule in the heart tissue and brains of living zebra fish larvae.

The sensor can be measured using a relatively new, non-invasive imaging method known as optoacoustics, which makes it suitable for use in living animals – and later possibly also in humans. The method is based on ultrasound technology, which is harmless for humans and uses no radiation. Laser pulses heat up the photoabsorbing sensor molecule in tissue. This causes the molecule to expand briefly, resulting in the generation of ultrasound signals. The signals are then sensed by ultrasound detectors and are translated into three-dimensional images.

As light passes through tissue, it is scattered. For this reason, images under a light microscope become blurred at depths of less than a millimeter. This highlights another advantage of optoacoustics: Ultrasound undergoes very little scattering, producing sharp images even at depths of several centimeters. This is particularly useful for examining the brain, because existing methods only penetrate a few millimeters below the brain surface. But the brain has such a complex three-dimensional structure with various functional areas that the surface only makes up a small part of it. The researchers therefore aim to use the new sensor to measure calcium changes deep inside living tissue. They have already achieved results in the brains of zebrafish larvae.

Additionally, the scientists have designed the sensor molecule so that it is easily taken up by living cells. Moreover, it is harmless to tissues and works based on a color change: as soon as the sensor binds to calcium, its color changes which in turn changes the light-induced optoacoustic signal.

Many imaging methods for visualizing calcium changes that are currently available require genetically modified cells. They are programmed, for example, to fluoresce whenever the calcium concentration in the cell changes. The problem with this, of course, is that it is not possible to carry out such genetic interventions in humans.

The new sensor overcomes this limitation, the scientists say. In the future, the researchers plan to refine the properties of the molecule further, allowing the sensor signals to be measured in even deeper tissue layers. To this end, the team headed by Westmeyer must generate further variants of the molecule that absorb light of a longer wavelength than cannot be perceived by the human eye.

For more information: www.pubs.acs.org

Related Optoacoustic Content

Seno Medical's Imagio Opto-Acoustic Breast Imaging System Proves Strong Predictor of Malignancy

Additional Data Validates Potential of Imagio Opto-Acoustic Breast Imaging System to Reduce Negative Biopsies

Imagio Opto-Acoustic Breast Imaging System Helps Differentiate Tumor Subtypes

 

Related Content

Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Fujifilm Exhibits Enterprise Imaging Solutions and Artificial Intelligence Initiative at HIMSS 2019
News | Enterprise Imaging | February 15, 2019
Fujifilm Medical Systems U.S.A. Inc. and Fujifilm SonoSite Inc. showcased their enterprise imaging and informatics...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease
News | Cardiac Imaging | February 11, 2019
The American College of Cardiology (ACC), along with nine other cardiology professional societies, recently published a...
Videos | Angiography | February 08, 2019
This is an example of an arterial venous malformation (AVM) in the brain imaged on a...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...
Epiq Elite for Obstetrics and Gynecology delivers high image quality and lifelike 3-D scans

The Epiq Elite for Obstetrics & Gynecology. Image courtesy of Philips Healthcare.

Technology | Ultrasound Imaging | February 07, 2019
Philips announced the launch of the Epiq Elite ultrasound system, a new premium ultrasound that combines the latest...
Canon Medical Debuts Alphenix 4-D CT at RSNA 2018
Technology | Angiography | February 06, 2019
Canon Medical Systems USA Inc. recently introduced a new angiography configuration featuring its Alphenix Sky + C-arm...
ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi